The Associated Press<\/font><\/strong>
By CHUCK BARTELS
April 10, 2012<\/div>\n
<\/font><\/strong><\/p>\nLITTLE ROCK, Arkansas<\/font><\/strong> — A Johnson & Johnson subsidiary downplayed and hid risks associated with the antipsychotic drug Risperdal, a jury determined Tuesday in Arkansas’ billion-dollar lawsuit against Janssen Pharmaceuticals Inc. Arkansas Attorney General Dustin McDaniel’s office is seeking fines of at least $1.2 billion for the 250,000 Risperdal prescriptions the state’s Medicaid program paid for over 3½ years. The penalty will be decided in a separate hearing Wednesday before Circuit Judge Tim Fox<\/font><\/strong>, who presided over the trial…<\/p>\n The 12-person jury returned its verdict after about three hours of deliberations<\/font><\/strong>. Jurors, who heard 10 days of testimony, weren’t told about the financial stakes, beyond that Janssen could have seen a $200 million swing in its revenues if it issued alarming warnings that the drug could cause weight gain, diabetes and other health effects. The award would go toward the state’s Medicaid fund…<\/p>\n Other states that have sued over Risperdal include Texas, which reached a $158 million settlement with Janssen in January but did not admit fault. Texas had sought damages of about $1 billion. In December, a South Carolina judge upheld a $327 million civil penalty against Johnson & Johnson. Jurors in Arkansas had a set of 10 questions to decide — five regarding Janssen and five for its Johnson & Johnson parent company. The jury ruled in favor of the state on all 10 questions.<\/font><\/strong> Only nine votes were needed to reach a decision on any question. Several of the decisions were split 11-1 or 10-2.<\/sup><\/div>\n<\/blockquote>\n![](\"http:\/\/1boringoldman.com\/images\/cards.gif\")
<\/div>\n","protected":false},"excerpt":{"rendered":"
Jury rules against J&J subsidiary in Arkansas The Associated Press By CHUCK BARTELS April 10, 2012 LITTLE ROCK, Arkansas — A Johnson & Johnson subsidiary downplayed and hid risks associated with the antipsychotic drug Risperdal, a jury determined Tuesday in Arkansas’ billion-dollar lawsuit against Janssen Pharmaceuticals Inc. Arkansas Attorney General Dustin McDaniel’s office is seeking […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-21978","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/21978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=21978"}],"version-history":[{"count":7,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/21978\/revisions"}],"predecessor-version":[{"id":21986,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/21978\/revisions\/21986"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=21978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=21978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=21978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}